(HealthDay)—A single intravenous bolus of tenecteplase reduces early death and hemodynamic decompensation in normotensive patients with intermediate-risk pulmonary embolism, but increases the risk of major hemorrhage and ...
Apr 11, 2014
0
0
The families of four elderly people who died while taking an anti-clotting drug have filed a legal complaint against France's drugs safety body and Germany-based drugmaker Boehringer Ingelheim, their lawyers said Wednesday.
Oct 9, 2013
0
0
(HealthDay)—Patients with heart valve replacements have greater rates of thromboembolic and bleeding complications after treatment with dabigatran compared with warfarin, according to a study published online Sept. 1 in ...
Sep 4, 2013
0
0
Linagliptin (trade name Trajenta) has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market ...
Jan 30, 2013
0
0
(AP)—A panel of federal health experts is overwhelmingly recommending approval for a long-acting inhaler to treat people suffering from chronic lung disease.
Jan 29, 2013
0
0
